Repare Therapeutics Inc

Repare Therapeutics Inc. is a pharmaceutical company dedicated to developing innovative oncology drugs that target specific vulnerabilities in tumor cells, offering new hope to cancer patients.

Repare Therapeutics Inc. has out-licensed its discovery platforms to DCx Biotherapeutics, but faces financial challenges and declining stock value, raising questions about its future trajectory and ability to deliver on its promises.